Feb 8 (Reuters)-
Medrx.Co., Ltd.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2018 Dec 31, 2017 Dec 31, 2019 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 8 mln 198 mln 1.01 19 mln
(-95.8 pct) (+787.2 pct) (+133.9 pct)
Operating loss 1.27 loss 983 mln loss 650 mln loss 811 mln
Recurring loss 1.29 loss 988 mln loss 656 mln loss 819 mln
Net
Net loss 1.27 loss 884 mln loss 643 mln loss 805 mln
EPS loss 126.77 yen loss 103.16 yen loss 63.03 yen loss 78.91 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Medrx.Co., Ltd..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4586.T